NPM1 MRD Status Is a Dominant Predictor of AML Relapse After AlloHCT

Disease relapse after allogeneic hematopoietic cell transplantation (alloHCT) remains the leading cause of treatment failure for patients with acute myeloid leukemia (AML), but measurable residual disease (MRD) testing after first complete…